SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-05-015629
Filing Date
2005-02-01
Accepted
2005-01-31 20:42:40
Documents
1
Group Members
ALEXANDER E. JACKSONKINGS ROAD INVESTMENTS LTD.PADDY DEARPOLYGON INVESTMENT MANAGEMENT LTD.POLYGON INVESTMENT PARTNERS GP, LLCPOLYGON INVESTMENT PARTNERS LLPPOLYGON INVESTMENT PARTNERS LPPOLYGON INVESTMENTS LTD.READE E. GRIFFITH

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G dsc13g.htm SC 13G 206291
  Complete submission text file 0001193125-05-015629.txt   208099
Mailing Address 397 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 397 EAGLEVIEW BLVD EXTON PA 19341 6104587300
VIROPHARMA INC (Subject) CIK: 0000946840 (see all company filings)

IRS No.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48239 | Film No.: 05563612
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 DUKE OF YORK SQUARE LONDON X0 SW34LY
Business Address 10 DUKE OF YORK SQUARE LONDON X0 SW34LY 442079018300
POLYGON GLOBAL OPPORTUNITIES MASTER FUND (Filed by) CIK: 0001278736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G